Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Crospon, Inc.
New imaging technology employed through a therapeutic endoscope provides the most relevant information to diagnose gastroesophageal reflux disease (GERD), according to its manufacturer, Crospon. Furthermore, the Irish start-up says its novel EndoFLIP (endoscopic functional lumen imaging probe) technology can be used to assist in GERD surgeries and to assess the results.
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, "Nanotechnology, a Balm for the Challenges of Drug Delivery," features profiles of BIND Biosciences, Liquidia Technologies, Nanolymf, Tempo Pharmaceuticals, and TransGenex Nanobiotech. Plus these Start-Ups Across Health Care: Breathe Technologies, Crospon, and InterMed Discovery.
A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
- Diagnostic Imaging Equipment & Supplies
- Monitoring Equipment & Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
- Other Names / Subsidiaries
- Janisys Ltd.